TALPHERA, INC. Investment Income, Net
TALPHERA, INC. (TLPH) reported Investment Income, Net of $172.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-12
- TALPHERA, INC. investment income, net for the quarter ending 2026-06-30 was $172.00K, a 107.23% increase year-over-year.
- TALPHERA, INC. investment income, net for the quarter ending 2026-03-31 was $169.00K, a 144.93% increase year-over-year.
- TALPHERA, INC. investment income, net for the quarter ending 2025-12-31 was $203.00K, a 97.09% increase year-over-year.
- TALPHERA, INC. investment income, net for the quarter ending 2025-09-30 was $81.00K, a 47.74% decline year-over-year.
- TALPHERA, INC. investment income, net for fiscal 2025 was $436.00K, a 35.79% decline from fiscal 2024.
- TALPHERA, INC. investment income, net for fiscal 2024 was $679.00K, a 52.05% decline from fiscal 2023.
- TALPHERA, INC. investment income, net for fiscal 2023 was $1.42M, a 286.89% increase from fiscal 2022.
- TALPHERA, INC. investment income, net for fiscal 2022 was $366.00K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 3 month as first filed | Investment Income, Net 6 month | Investment Income, Net 6 month as first filed | Investment Income, Net 9 month | Investment Income, Net 9 month as first filed | Investment Income, Net 12 month | Investment Income, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $172.00K 10-Q · filed 2026-08-12 | $341.00K 10-Q · filed 2026-08-12 | $544.00K derived: sum of 3 quarters · filed 2026-08-12 | $625.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $169.00K 10-Q · filed 2026-05-13 | $372.00K derived: sum of 2 quarters · filed 2026-05-13 | $453.00K derived: sum of 3 quarters · filed 2026-05-13 | $536.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $284.00K derived: sum of 2 quarters · filed 2026-03-23 | $367.00K derived: sum of 3 quarters · filed 2026-08-12 | $436.00K 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $81.00K 10-Q · filed 2025-11-12 | $164.00K derived: sum of 2 quarters · filed 2026-08-12 | $233.00K 10-Q · filed 2025-11-12 | $336.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $83.00K 10-Q · filed 2026-08-12 | $152.00K 10-Q · filed 2026-08-12 | $255.00K derived: sum of 3 quarters · filed 2026-08-12 | $410.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $69.00K 10-Q · filed 2026-05-13 | $172.00K derived: sum of 2 quarters · filed 2026-05-13 | $327.00K derived: sum of 3 quarters · filed 2026-05-13 | $528.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $258.00K derived: sum of 2 quarters · filed 2026-03-23 | $459.00K derived: sum of 3 quarters · filed 2026-03-23 | $679.00K 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $155.00K 10-Q · filed 2025-11-12 | $356.00K derived: sum of 2 quarters · filed 2025-11-12 | $576.00K 10-Q · filed 2025-11-12 | $747.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $201.00K 10-Q · filed 2025-08-14 | $421.00K 10-Q · filed 2025-08-14 | $592.00K derived: sum of 3 quarters · filed 2025-08-14 | $779.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $220.00K 10-Q · filed 2025-05-14 | $391.00K derived: sum of 2 quarters · filed 2025-05-14 | $578.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.44M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $358.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.22M derived: sum of 3 quarters · filed 2025-03-31 | $1.42M 10-K · filed 2025-03-31 | $6.74M 10-K · filed 2024-03-06 | |||
| 2023-09-30 | $187.00K 10-Q · filed 2024-11-13 | $1.89M 10-Q · filed 2023-11-14 | $1.04M derived: sum of 2 quarters · filed 2024-11-13 | $1.25M 10-Q · filed 2024-11-13 | $6.96M 10-Q · filed 2023-11-14 | $1.38M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $858.00K 10-Q · filed 2024-08-14 | -$441.00K 10-Q · filed 2023-08-10 | $1.06M 10-Q · filed 2024-08-14 | $5.07M 10-Q · filed 2023-08-10 | $1.20M derived: sum of 3 quarters · filed 2024-08-14 | $1.33M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-14 | $5.51M 10-Q · filed 2023-05-10 | $337.00K derived: sum of 2 quarters · filed 2024-05-14 | $477.00K derived: sum of 3 quarters · filed 2024-05-14 | $528.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $277.00K derived: sum of 2 quarters · filed 2024-03-06 | $328.00K derived: sum of 3 quarters · filed 2024-03-06 | $366.00K 10-K · filed 2024-03-06 | ||||
| 2022-09-30 | $140.00K 10-Q · filed 2023-11-14 | $191.00K derived: sum of 2 quarters · filed 2023-11-14 | $229.00K 10-Q · filed 2023-11-14 | $261.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $51.00K 10-Q · filed 2023-08-10 | $89.00K 10-Q · filed 2023-08-10 | $121.00K derived: sum of 3 quarters · filed 2023-08-10 | $153.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $38.00K 10-Q · filed 2023-05-10 | $70.00K derived: sum of 2 quarters · filed 2023-08-01 | $102.00K derived: sum of 3 quarters · filed 2023-08-01 | $86.00K derived: sum of 4 quarters · filed 2023-08-01 | ||||
| 2021-12-31 | $32.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | $64.00K derived: sum of 2 quarters · filed 2023-08-01 | $48.00K derived: sum of 3 quarters · filed 2023-08-01 | $124.00K 8-K · filed 2023-08-01 | ||||
| 2021-09-30 | $32.00K 10-Q · filed 2022-11-14 | $16.00K derived: sum of 2 quarters · filed 2022-11-14 | $92.00K 10-Q · filed 2022-11-14 | $364.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$16.00K 10-Q · filed 2022-08-11 | $60.00K 10-Q · filed 2022-08-11 | $332.00K derived: sum of 3 quarters · filed 2022-08-11 | $438.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $76.00K 10-Q · filed 2022-05-16 | $348.00K derived: sum of 2 quarters · filed 2022-05-16 | $454.00K derived: sum of 3 quarters · filed 2022-05-16 | $724.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $378.00K derived: sum of 2 quarters · filed 2022-03-10 | $648.00K derived: sum of 3 quarters · filed 2022-03-10 | $583.00K 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $106.00K 10-Q · filed 2021-11-15 | $376.00K derived: sum of 2 quarters · filed 2021-11-15 | $311.00K 10-Q · filed 2021-11-15 | $749.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $270.00K 10-Q · filed 2021-08-16 | $205.00K 10-Q · filed 2021-08-16 | $643.00K derived: sum of 3 quarters · filed 2021-08-16 | $1.29M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$65.00K 10-Q · filed 2021-05-17 | $373.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.02M derived: sum of 3 quarters · filed 2021-05-17 | $1.47M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $438.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $1.08M derived: sum of 2 quarters · filed 2021-03-15 | $1.54M derived: sum of 3 quarters · filed 2021-03-15 | $2.17M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $645.00K 10-Q · filed 2020-11-05 | $1.10M derived: sum of 2 quarters · filed 2020-11-05 | $1.73M 10-Q · filed 2020-11-05 | $2.22M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-06-30 | $456.00K 10-Q · filed 2020-08-10 | $1.08M 10-Q · filed 2020-08-10 | $1.58M derived: sum of 3 quarters · filed 2021-03-15 | $1.89M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-03-31 | $627.00K 10-Q · filed 2020-05-11 | $1.12M derived: sum of 2 quarters · filed 2021-03-15 | $1.43M derived: sum of 3 quarters · filed 2021-03-15 | $1.63M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2018-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $807.00K derived: sum of 2 quarters · filed 2021-03-15 | $1.00M derived: sum of 3 quarters · filed 2021-03-15 | $1.14M 10-K · filed 2021-03-15 | ||||
| 2018-09-30 | $312.00K 10-Q · filed 2019-11-07 | $507.00K derived: sum of 2 quarters · filed 2019-11-07 | $643.00K 10-Q · filed 2019-11-07 | $1.37M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-06-30 | $195.00K 10-Q · filed 2019-08-06 | $331.00K 10-Q · filed 2019-08-06 | $1.06M derived: sum of 3 quarters · filed 2020-03-16 | $591.00K derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-03-31 | $136.00K 10-Q · filed 2019-05-09 | $861.00K derived: sum of 2 quarters · filed 2020-03-16 | $396.00K derived: sum of 3 quarters · filed 2020-03-16 | $792.00K derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2017-12-31 | $725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $260.00K derived: sum of 2 quarters · filed 2020-03-16 | $656.00K derived: sum of 3 quarters · filed 2020-03-16 | $510.00K 10-K · filed 2020-03-16 | ||||
| 2017-09-30 | -$465.00K 10-Q · filed 2018-11-05 | -$69.00K derived: sum of 2 quarters · filed 2018-11-05 | -$215.00K 10-Q · filed 2018-11-05 | $403.00K derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-06-30 | $396.00K 10-Q · filed 2018-08-02 | $250.00K 10-Q · filed 2018-08-02 | $868.00K derived: sum of 3 quarters · filed 2019-03-07 | $508.00K derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-03-31 | -$146.00K 10-Q · filed 2018-05-10 | $472.00K derived: sum of 2 quarters · filed 2019-03-07 | $112.00K derived: sum of 3 quarters · filed 2019-03-07 | $353.00K derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2016-12-31 | $618.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $258.00K derived: sum of 2 quarters · filed 2019-03-07 | $499.00K derived: sum of 3 quarters · filed 2019-03-07 | $918.00K 10-K · filed 2019-03-07 | ||||
| 2016-09-30 | -$360.00K 10-Q · filed 2017-11-09 | -$119.00K derived: sum of 2 quarters · filed 2017-11-09 | $300.00K 10-Q · filed 2017-11-09 | $105.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | $241.00K 10-Q · filed 2017-08-02 | $660.00K 10-Q · filed 2017-08-02 | $465.00K derived: sum of 3 quarters · filed 2018-03-09 | $196.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | $419.00K 10-Q · filed 2017-05-08 | $224.00K derived: sum of 2 quarters · filed 2018-03-09 | -$45.00K derived: sum of 3 quarters · filed 2018-03-09 | -$41.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | -$195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$464.00K derived: sum of 2 quarters · filed 2018-03-09 | -$460.00K derived: sum of 3 quarters · filed 2018-03-09 | $1.72M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | -$269.00K 10-Q · filed 2016-11-02 | -$265.00K derived: sum of 2 quarters · filed 2016-11-02 | $1.92M 10-Q · filed 2016-11-02 | $697.00K derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-06-30 | $4.00K 10-Q · filed 2016-07-29 | $2.18M 10-Q · filed 2016-07-29 | $966.00K derived: sum of 3 quarters · filed 2017-03-03 | $7.52M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-03-31 | $2.18M 10-Q · filed 2016-05-02 | $962.00K derived: sum of 2 quarters · filed 2017-03-03 | $7.52M derived: sum of 3 quarters · filed 2017-03-03 | |||||
| 2014-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $5.34M derived: sum of 2 quarters · filed 2017-03-03 | $6.93M 10-K · filed 2017-03-03 | |||||
| 2014-09-30 | $6.56M 10-Q · filed 2015-11-03 | $8.15M 10-Q · filed 2015-11-03 | ||||||
| 2013-12-31 | -$15.24M 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |